← Leaderboards
Hugo Guerrero-Cazares
Mayo Clinic Jacksonville
$2,987,288
Attributed
$2,987,288
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $879.6K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,987,288 · 5
By mechanism
K01$1,053,000 · 1
R01$884,125 · 1
R21$814,309 · 2
R03$235,854 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Jacksonville
Same institution · by research overlap
- Leonard Petrucelli$43,938,031
- James Shorter$11,511,778
- Tania France Gendron$4,632,093
- Andrew J Saykin$38,010,806
- Marka Van Blitterswijk$6,748,882
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoSelf-RenewalBrain NeoplasmsLocationCellsLateral VentricleTumorNerve Stem CellPrimary Brain NeoplasmsOperative Surgical ProceduresIn VitroGlioblastomaMalignant NeoplasmsMigrationAdultMalignant - DescriptorRecurrenceResponseSubventricular ZoneAffectCerebrospinal FluidReportingCell MotilitySampling
Grant awards (15)
Targeting Signaling Between Glioblastoma and the Subventricular Zone Niche$434,922
R01 · FY2025 · NS · contact PI
TARGETING SIGNALING BETWEEN GLIOBLASTOMA AND THE SUBVENTRICULAR ZONE NICHE$449,203
R01 · FY2024 · NS · contact PI
GLIOMA INTERACTION WITH THE NEUROGENIC NICHE THROUGH EXTRACELLULAR VESICLES$430,375
R21 · FY2024 · NS · contact PI
Osteopontin-CD44 role in the malignancy of lateral ventricle infiltrating glioblastoma$210,600
K01 · FY2023 · NS · contact PI
Osteopontin-CD44 role in the malignancy of lateral ventricle infiltrating glioblastoma$210,600
K01 · FY2022 · NS · contact PI
Osteopontin-CD44 role in the malignancy of lateral ventricle infiltrating glioblastoma$210,600
K01 · FY2021 · NS · contact PI
Osteopontin-CD44 role in the malignancy of lateral ventricle infiltrating glioblastoma$210,600
K01 · FY2020 · NS · contact PI
Osteopontin-CD44 role in the malignancy of lateral ventricle infiltrating glioblastoma$210,600
K01 · FY2019 · NS · contact PI
Role of SerpinA3 in the response of glioblastoma to cerebrospinal fluid$145,162
R03 · FY2019 · NS · contact PI
Role of SerpinA3 in the response of glioblastoma to cerebrospinal fluid$12,442
R03 · FY2019 · NS · contact PI
Role of SerpinA3 in the response of glioblastoma to cerebrospinal fluid$78,250
R03 · FY2018 · NS · contact PI
Role of Human Cerebrospinal Fluid Chemokines in the Invasiveness of Human Glioblastoma$170,194
R21 · FY2017 · CA · contact PI
Role of Human Cerebrospinal Fluid Chemokines in the Invasiveness of Human Glioblastoma$10,955
R21 · FY2017 · CA · contact PI
Role of Human Cerebrospinal Fluid Chemokines in the Invasiveness of Human Glioblastoma$3,443
R21 · FY2017 · CA · contact PI
Role of Human Cerebrospinal Fluid Chemokines in the Invasiveness of Human Glioblastoma$199,342
R21 · FY2016 · CA · contact PI